Clinopathologic Conference, Celiac Disease
NEJM 374:1875-1883, Case 14-2016, 2016
Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016
Risk of Cerebral Venous Thrombosis in Obese Women
JAMA Neurol 73:579-584, Zuurbier, S.M.,et al, 2016
Exploring the Association Between Rosacea and Parkinson Disease
JAMA Neurol 73:529-534, Egeberg, A.,et al, 2016
Which Oral Anticoagulation for Atrial Fibrillation?
JAMA 315:2117-2118, The Medical Letter, 2016
Aortic Dissections Type A during Sexual Intercourse in Male Patients: Accident or Systematic Coincidence? Examination of 365 Patients with Acute Aortic Dissection within 20 Years
Thorac Cardiovasc Surg 64:133-136, Gansera, L.,et al, 2016
Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients
Stroke 47:1555-1561, Shah, A.,et al, 2016
Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016
Risk of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and High Cerebral Microbleed Burden
JAMA Neurol 73:675-683,632, Tsivgoulis, G.,et al, 2016
Should Atrial Fibrillation Patients with only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
Stroke 47:1831-1836, Fauchier, L.,et al, 2016
Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage
Stroke 47:1837-1843, Ottosen, T.P.,et al, 2016
Postmenopausal Hormone Therapy and Risk of Stroke
Stroke 47:1734-1741, Canonico, M.,et al, 2016
Managing Risk After Intracerebral Hemorrhage in Concomitant Atrial Fibrillation and Cerebral Amyloid Angiopathy
Stroke 47:e190-e192, Stoker, T.B.,et al, 2016
Patients with Rosacea have Increased Risk of Dementia
Ann Neurol 79:921-928, Egeberg, A.,et al, 2016
Advanced Interatrial Block and Ischemic Stroke
Neurol 87:352-356, ONeal, W.T.,et al, 2016
Outcomes with Edoxaban Versus Warfarin in Patients with Previous Cerebrovascular Events
Stroke 47:2075-2082, Rost, N.S.,et al, 2016
Pathogenesis and Risk Factors for Cerebral Infarct After Surgical Aortic Valve REplacement
Stroke 47:2130-2132, Massor, Al.,et al, 2016
Incidence of Radiologically Isolated Syndrome: A Population-Based Study
AJNR 37:1017-1022, Forslin, Y.,et al, 2016
Idiopathic Thoracic Spontaneous Spinal Epidural Hematoma
Case Reports Surg doi:10.1155/2016/5430708, Aycan, A.,et al, 2016
Myasthenia Gravis after Botulinum Toxin Type A Injection
Turk J Neurol 22:143-144, Tekce, H.D.,et al, 2016
Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Eur J Cancer 54:139-148, Michot, JM,.,et al, 2016
Acute Demyelinating Polyneuropathy Caused by Nivolumab in a Man with Metastatic Non-Small Cell Lung Cancer
J Gerontol Geriatr Res 5:3, Sabeeh-Ur-Rehman, B. & Bhaumik, S., 2016
Trousseaus Syndrome: Cancer-Associated Thrombosis
Jpn J Clin Oncol 46:204-207, Ikushima, S.,et al, 2016
Cysticercal Encephalitis: An Unusual Differential in the List of Encephalitis
IJCMR 3:2264-2266, Ajeet, S.,et al, 2016
Differential Diagnosis
Thoracic Key, Southerland,A.W.,et al, 2016
Emerging Cases of Powassan Virus Encephalitis in New England:Clinical Presentation, Imaging, and Review of the Literature
CID 62:707-713, Piantadosi,A.,et al, 2016
Small Fiber Neuropathy in Fabry Disease:A Review of Pathophysiology and Treatment
JIEMS 4:1-5, Politeri,J.M.,et al, 2016
Paraneoplastic Cerebellar Degeneration with Anti-Yo Antibodies - A Review
Ann Clin Trans Neurol 3:655-663, Venkatraman,A. & Opal,P., 2016
Carbon Monoxide Poisoning and Risk of Deep Vein Thrombosis and Pulmonary Embolism:A Nationwide Retrospectice Cohort Study
J Epidemiol Comm Health 69:557-562, Chung,W-S.,et al, 2015
Risk of Recurrent Neurologic Stroke or Transient Ischemic Attack in Patients with Cryptogenic Stroke and Intrapulmonary Shunt
Echocardiography 33:276-280, Sinha, R.S.,et al, 2015
Factors Associated with Mortality in Extrapulmonary Tuberculosis Patients at a Teaching Hospital in Ghana
Ghana Med J 49:233-238, Nassikas, N.,et al, 2015
Reversible Cerebral Vasoconstriction Syndromes
MedLink Aug, Singhai, A.B. & Levine, S.R., 2015
Clinicopathologic Conference, Malaria
NEJM 373:1060-1067, Case 28-2015, 2015
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015
Non-Alzheimers Dementia 3 Vascular Dementia
Lancet 386:1698-1706, OBrien, J.T. & Thomas, A., 2015
Risk of Stroke in Retinal Vein Occlusion
Neurol 85:1578-1584, Park, S.J.,et al, 2015
Clinical Features, Diagnosis, and Treatment of Disseminated Intravascular Coagulation in Adults
UptoDate, Leung, L.L.K., 2015
Cavernous Sinus Thrombosis in Children
Stroke 46:2657-2660, Press, C.A.,et al, 2015
Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis
Stroke 46:2477-2481, Findlay, M.D.,et al, 2015
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
NEJM 373:823-833, Douketis,J.D.,et al, 2015
Association Between Anemia and Cerebral Venous Thrombosis
Stroke 46:2735-2740, Coutinho, J.M.,et al, 2015
Recurrent Stroke in Childhood Cancer Survivors
Neurol 85:1056-1064, Fullerton, H.J.,et al, 2015
Lithium Therapy in Kleine-Levin Syndrome
Neurol 85:1655-1662, Leu-Semenescu, S.,et al, 2015
Peri-Procedural Management of Patients Taking Oral Anticoagulants
BMJ 351:h2391, Daniels, P.R., 2015
Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users
Stroke 46:e167-e169, Baud, M.O.,et al, 2015
Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015
Cerebral Microbleeds Predict Intracerebral Hemorrhage in Hemodialysis Patients
Stroke 46:2107-2112, Naganuma, T.,et al, 2015
Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course
AJNR 36:1392-1399, Miller, T.R.,et al, 2015